Navigation Links
Dynatronics Announces First Quarter Financial Results

SALT LAKE CITY, Nov. 14, 2013 /PRNewswire/ -- Dynatronics Corporation (NASDAQ: DYNT) today announced results for its fiscal first quarter ended September 30, 2013.

Net sales in the quarter decreased 2.1% to $7,055,428, compared to $7,206,025 in the same period of the prior year. Net loss for the quarter was $107,784 ($.04 per common share), compared to $51,145 ($.02 per common share) for the prior year period.  The loss was primarily the result of lower sales of products manufactured by third parties, as well as approximately $49,000 in higher R&D costs this quarter associated with the company's new ThermoStim probe, a product expected to launch during the quarter ending December 31, 2013.  All per-share amounts reflect the company's one-for-five reverse stock split, effective December 19, 2012.

"While sales of manufactured capital products and supplies remained even or improved, reduced sales of distributed medical products and supplies, including exercise products, nutritional supplements and taping products, accounted for the decrease in sales for the quarter ended September 30, 2013, compared to the prior year period," stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "The continued general economic weakness in our primary markets, combined with uncertainties surrounding the implementation of the Affordable Care Act, have dampened demand and contributed to lower sales numbers.

"To offset these challenges, management has undertaken a plan to significantly expand the company's distribution channels by adding new dealers and sales representatives," Cullimore continued, "To date, we have added more than 30 new sales representatives to our distribution channel. These new representatives are independent direct sales reps and sales reps at newly added independent dealers. They will augment our geographical reach to practitioners across the country. The addition of these new reps brings us nearly halfway to our goal of adding 75 new sales representatives selling our products."

"We've also developed a major new product that we expect to introduce in the quarter ending December 31, 2013," reported Larry K. Beardall, executive vice president of sales and marketing. "This is the Dynatron Thermostim Probe™, and will be one of the most innovative and attractive products in our history. The Thermostim Probe is a soft-tissue mobilization tool that also allows a practitioner to deliver heat or cold therapy in combination with electrical stimulation – all at the same time."The new hand-held probe is an accessory to the Dynatron SolarisPlus family of products. It utilizes a thermoelectric chip to generate the thermal therapy and is powered by any one of four Dynatron SolarisPlus units.

"Demand for this innovative probe is building even before it is released," stated Beardall. "We now have indications of interest from over 500 clinicians across the country who have become aware of this innovative new product. And since the probe is operated from the control console of the SolarisPlus units, we expect demand for SolarisPlus units to rise commensurate with the demand for the ThermoStim probe."

"We believe the introduction of the new Thermostim probe, together with the expansion of our distribution channel, will be the impetus to return Dynatronics to profitability," Cullimore concluded.

Dynatronics has scheduled a conference call for investors today, Thursday, November 14, 2013, at 12:30 p.m. ET. Those wishing to participate should call (800) 954-0586.

The following is a summary of the financial results as of September 30, 2013 and 2012, and for the quarter then ended:  Summary Selected Financial DataStatement of Operations HighlightsThree Months Ended
September 30,20132012Net sales


7,055,4287,206,025Cost of sales4,474,3594,495,177Gross profit2,581,0692,710,848Selling, general, and administrative expenses2,379,3692,459,104Research and development expenses314,823266,268Total other expense55,38659,085Loss before income tax benefit (168,509)(73,609)Income tax benefit 60,72522,464Net  loss


(107,784)(51,145)Diluted net loss per common share


(0.04)(0.02) Balance Sheet Highlights As of September 30,20132012Cash and cash equivalents


220,660302,050Trade accounts receivable3,256,4323,246,712Inventories, net6,255,3176,407,553Total current assets10,748,42410,879,449Total assets


14,900,15615,104,587Line of credit3,616,6013,496,390Accounts payable2,453,4412,751,894Accrued expenses388,855347,221Accrued payroll and benefits expense325,318216,266Total liabilities8,781,0718,895,637Total liabilities and stockholders' equity


14,900,15615,104,587About Dynatronics Corporation:Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at

Safe Harbor NotificationThis press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding expectations for future new product introductions and plans to expand distribution. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost-effective rates, and the risk factors listed from time to time in the company's SEC reports.

SOURCE Dynatronics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics To Release Fiscal First Quarter Results Thursday, November 14, 2013;
2. Dynatronics Announced Changes in Todays Conference Call Monday, September 30, 2013; Conference Call set for 4:30 p.m. ET
3. Dynatronics Announces Year-End Financial Results
4. Dynatronics To Release Fiscal 2013 Year-end Results Monday, September 30, 2013; Conference Call set for 3:30 p.m. ET
5. Dynatronics Appoints R. Scott Ward, PT PhD to its Board of Directors
6. Dynatronics Announces Third Quarter Results
7. Dynatronics To Release Fiscal Third Quarter Results Tuesday, May 14, 2013; Conference Call set for 1:30 p.m. ET
8. Dynatronics Second Quarter Profits Jump 204%
9. Dynatronics To Release Fiscal Second Quarter Results Wednesday, February 13, 2013; Conference Call set for 3:00 p.m. ET
10. Dynatronics Announces First Quarter Results
11. Dynatronics To Release Fiscal First Quarter Results Wednesday, November 14, 2012; Conference Call set for 4:30 p.m. ET
Post Your Comments:
(Date:11/26/2015)... ) has ... Future Horizons and Growth Strategies in the ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> ) has announced the ... and Growth Strategies in the French Drugs ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Therapeutic Drug Monitoring (TDM) Market: Supplier ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Marker Testing Market: Supplier Shares, Competitive ... offering.  --> ) ... "2016 Future Horizons and Growth Strategies ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the ... 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the ... Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention Center ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast cancers ... on mammography, according to a study published online in the journal Radiology. Researchers ... mammography may necessitate a change in treatment. , Breast MRI is the most ...
(Date:11/25/2015)... ... 2015 , ... Medical Solutions, one of the nation’s top ... culture with the company’s Cincinnati office being named a finalist among greater Cincinnati’s ... a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati Best Places to ...
(Date:11/25/2015)... LA (PRWEB) , ... November 25, 2015 , ... On ... the United States District Court of Connecticut on behalf of a home health care ... of all current or former home health care workers employed by Humana, Inc., Humana ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Dental professionals ... in Cleveland, OH , are invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring ... year in Cleveland, OH. , As the co-founders of Advanced Implant Mentoring (AIM), ...
Breaking Medicine News(10 mins):